Dyne Therapeutics DYN
NASDAQ DYN
$16.25 +0.04 (+0.25%)
As of: Sep 30, 2026 · 1:05 PM EDT

Dyne Therapeutics, Inc. (DYN) Cash from Operations (2019 - 2026)

Updated

Dyne Therapeutics (DYN) posted Cash from Operations of -$130.29 million for Q2 2026, compared with -$94.7 million a year earlier.

Analysis

Dyne Therapeutics, Inc. (DYN) Cash from Operations (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cash from Operations at Dyne Therapeutics was -$477.82 million; for FY2025, it was -$403.21 million.

  • In prior years, Dyne Therapeutics' Cash from Operations was -$292.37 million in FY2024, -$188.16 million in FY2023, -$153.65 million in FY2022 and -$119.56 million in FY2021.
  • Quarterly Cash from Operations has run from a low of -$144.92 million in Q1 2026 to a high of -$26.95 million in Q3 2021 over five years.
  • According to Business Quant data, Cash from Operations for the three prior quarters was -$144.92 million (Q1 2026), -$111.83 million (Q4 2025) and -$90.78 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -130.29 Mn
Mar 31, 2026 -144.92 Mn
Dec 31, 2025 -111.83 Mn
Sep 30, 2025 -90.78 Mn
Jun 30, 2025 -94.70 Mn
Mar 31, 2025 -105.89 Mn
Dec 31, 2024 -84.34 Mn
Sep 30, 2024 -74.63 Mn
Jun 30, 2024 -54.87 Mn
Mar 31, 2024 -78.54 Mn
Dec 31, 2023 -35.01 Mn
Sep 30, 2023 -50.60 Mn
Jun 30, 2023 -55.64 Mn
Mar 31, 2023 -46.91 Mn
Dec 31, 2022 -29.19 Mn
Sep 30, 2022 -42.81 Mn
Jun 30, 2022 -30.91 Mn
Mar 31, 2022 -50.74 Mn
Dec 31, 2021 -28.07 Mn
Sep 30, 2021 -26.95 Mn
API Access

Dyne Therapeutics, Inc. Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=DYN&period=max&api_key=YOUR_API_KEY